Trastuzumab deruxtecan (T-Dxd DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Vaz Batista, M.
Perez-Garcia, J. M.
Llombart Cussac, A.
Cortez, P.
Ruiz Borrego, M.
De la Haba, J.
Cejalvo, J. M.
Racca, F.
Servitja, S.
Blanch, S.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
